Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:55 pm Sale | 13G | Decibel Therapeutics Inc. DBTX | CITADEL ADVISORS LLC | 0 0.000% | -1,863,411 (Position Closed) | View |
| 2023-09-27 4:05 pm Sale | 13D | Decibel Therapeutics Inc. DBTX | REGENERON PHARMACEUTICALS INC. REGN | 100 100.000% | -2,097,214 (-100.00%) | View |
| 2023-08-18 5:16 pm Unchanged | 13D | Decibel Therapeutics Inc. DBTX | REGENERON PHARMACEUTICALS INC. REGN | 2,097,314 8.300% | 0 (Unchanged) | View |
| 2023-02-14 08:02 am Purchase | 13G | Decibel Therapeutics Inc. DBTX | CITADEL ADVISORS LLC | 1,863,411 7.500% | 35,484 (+1.94%) | View |
| 2023-02-03 12:09 pm Purchase | 13G | Decibel Therapeutics Inc. DBTX | BlackRock Inc. BLK | 1,805,108 7.200% | 1,805,108 (New Position) | View |
| 2022-02-14 5:03 pm Purchase | 13G | Decibel Therapeutics Inc. DBTX | Third Rock Ventures III L.P. | 3,139,685 12.600% | 3,139,685 (New Position) | View |
| 2022-02-14 12:30 pm Purchase | 13G | Decibel Therapeutics Inc. DBTX | GV 2016 L.P. | 1,636,258 6.570% | 1,636,258 (New Position) | View |
| 2022-02-14 06:12 am Purchase | 13G | Decibel Therapeutics Inc. DBTX | CITADEL ADVISORS LLC | 1,827,927 7.300% | 39,484 (+2.21%) | View |
| 2022-02-11 4:05 pm Purchase | 13G | Decibel Therapeutics Inc. DBTX | REGENERON PHARMACEUTICALS INC. REGN | 2,097,314 8.420% | 2,097,314 (New Position) | View |
| 2021-03-01 6:13 pm Purchase | 13D | Decibel Therapeutics Inc. DBTX | ORBIMED ADVISORS LLC | 4,061,774 16.700% | 4,061,774 (New Position) | View |
| 2021-03-01 4:01 pm Purchase | 13G | Decibel Therapeutics Inc. DBTX | CITADEL ADVISORS LLC | 1,788,443 7.400% | 1,788,443 (New Position) | View |